Cargando…
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health system...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401371/ https://www.ncbi.nlm.nih.gov/pubmed/36033124 http://dx.doi.org/10.24926/iip.v12i4.4328 |
_version_ | 1784772954188414976 |
---|---|
author | Rackimuthu, Sudhan Kazmi, Zohra Osman Elmahi, Osman Kamal Hunain, Reem Ghazi, Behram Khan Zaidi, Zain Ali Costa, Ana Carla dos Santos Ahmad, Shoaib Essar, Mohammad Yasir |
author_facet | Rackimuthu, Sudhan Kazmi, Zohra Osman Elmahi, Osman Kamal Hunain, Reem Ghazi, Behram Khan Zaidi, Zain Ali Costa, Ana Carla dos Santos Ahmad, Shoaib Essar, Mohammad Yasir |
author_sort | Rackimuthu, Sudhan |
collection | PubMed |
description | Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health systems, and rising costs of healthcare delivery with concomitant rising inequity with regards to access to health services amid the COVID-19 pandemic. The pandemic itself has stimulated an increased use of phytotherapy in Africa as a result of essential drug shortages that have been attributed to a plethora of contributing factors such as travel restrictions, reduced per capita income as well as increased expenditure on transport. As a result, the paucity of antiviral along with antiretroviral drugs used to combat COVID-19 as well as several other endemic viral diseases in Africa has created a worrisome state. This article therefore discusses and aims to underscore the causes, effects, and implications of antiviral and antiretroviral shortages amid COVID-19 in Africa. |
format | Online Article Text |
id | pubmed-9401371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | University of Minnesota Libraries Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-94013712022-08-25 Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling Rackimuthu, Sudhan Kazmi, Zohra Osman Elmahi, Osman Kamal Hunain, Reem Ghazi, Behram Khan Zaidi, Zain Ali Costa, Ana Carla dos Santos Ahmad, Shoaib Essar, Mohammad Yasir Innov Pharm Commentary Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health systems, and rising costs of healthcare delivery with concomitant rising inequity with regards to access to health services amid the COVID-19 pandemic. The pandemic itself has stimulated an increased use of phytotherapy in Africa as a result of essential drug shortages that have been attributed to a plethora of contributing factors such as travel restrictions, reduced per capita income as well as increased expenditure on transport. As a result, the paucity of antiviral along with antiretroviral drugs used to combat COVID-19 as well as several other endemic viral diseases in Africa has created a worrisome state. This article therefore discusses and aims to underscore the causes, effects, and implications of antiviral and antiretroviral shortages amid COVID-19 in Africa. University of Minnesota Libraries Publishing 2021-09-22 /pmc/articles/PMC9401371/ /pubmed/36033124 http://dx.doi.org/10.24926/iip.v12i4.4328 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Rackimuthu, Sudhan Kazmi, Zohra Osman Elmahi, Osman Kamal Hunain, Reem Ghazi, Behram Khan Zaidi, Zain Ali Costa, Ana Carla dos Santos Ahmad, Shoaib Essar, Mohammad Yasir Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title | Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_full | Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_fullStr | Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_full_unstemmed | Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_short | Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling |
title_sort | antiviral and antiretroviral drug shortages amidst covid-19: how africa is struggling |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401371/ https://www.ncbi.nlm.nih.gov/pubmed/36033124 http://dx.doi.org/10.24926/iip.v12i4.4328 |
work_keys_str_mv | AT rackimuthusudhan antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT kazmizohra antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT osmanelmahiosmankamal antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT hunainreem antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT ghazibehramkhan antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT zaidizainali antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT costaanacarladossantos antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT ahmadshoaib antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling AT essarmohammadyasir antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling |